标题
An update on brivaracetam for the treatment of pediatric partial epilepsy
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-9
出版商
Informa UK Limited
发表日期
2021-04-26
DOI
10.1080/14656566.2021.1921151
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis
- (2020) Christian Brandt et al. EPILEPSY & BEHAVIOR
- Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial
- (2020) Terence J. O’Brien et al. EPILEPSIA
- Mechanisms of action of currently used antiseizure drugs
- (2020) Graeme J. Sills et al. NEUROPHARMACOLOGY
- Clinical experience with brivaracetam in a series of 46 children
- (2020) Núria Visa-Reñé et al. EPILEPSY & BEHAVIOR
- A review of the drug−drug interactions of the antiepileptic drug brivaracetam
- (2020) Brian D. Moseley et al. EPILEPSY RESEARCH
- Potential role of brivaracetam in pediatric epilepsy
- (2020) Alberto Verrotti et al. ACTA NEUROLOGICA SCANDINAVICA
- Time course of drug-related treatment-emergent adverse side effects of brivaracetam
- (2020) Kimford J. Meador et al. EPILEPSY & BEHAVIOR
- Pharmacokinetic considerations for anti-epileptic drugs in children
- (2019) Alberto Verrotti et al. Expert Opinion on Drug Metabolism & Toxicology
- Brivaracetam in adults with drug-resistant epilepsy and psychiatric comorbidities
- (2019) Evangelia Theochari et al. EPILEPSY & BEHAVIOR
- Brivaracetam for epilepsy
- (2019) Van Hellerslia et al. JAAPA-Journal of the American Academy of Physician Assistants
- Intravenous Brivaracetam in the Treatment of Status Epilepticus: A Systematic Review
- (2019) Francesco Brigo et al. CNS DRUGS
- Effects of cannabidiol on brivaracetam plasma levels
- (2019) Kerstin A. Klotz et al. EPILEPSIA
- Use of intravenous brivaracetam in status epilepticus: A multicenter registry
- (2019) Estevo Santamarina et al. EPILEPSIA
- Recent advances in the pharmacotherapy of epilepsy: brivaracetam and perampanel as broad-spectrum antiseizure drugs for the treatment of epilepsies and status epilepticus
- (2019) Laurent Maximilian Willems et al. EXPERT OPINION ON PHARMACOTHERAPY
- Brivaracetam efficacy and safety in focal epilepsy
- (2019) Yamane Makke et al. Expert Review of Neurotherapeutics
- Effect of brivaracetam on the anger levels of epilepsy patients. A prospective open-labelled controlled study
- (2019) Manuel Toledo et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients
- (2019) Edwin Liu et al. PEDIATRIC DRUGS
- Safety and tolerability of adjunctive brivaracetam in children with focal seizures: Interim analysis of pooled data from two open-label trials
- (2019) Anup D. Patel et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Safety and Efficacy of Brivaracetam in Pediatric Refractory Epilepsy: A Single-Center Clinical Experience
- (2019) Sara McGuire et al. JOURNAL OF CHILD NEUROLOGY
- Treatment with brivaracetam in children – The experience of a pediatric epilepsy center
- (2019) Andreea Nissenkorn et al. EPILEPSY & BEHAVIOR
- Pharmacokinetic interaction of brivaracetam on other antiepileptic drugs in adults with focal seizures: Pooled analysis of data from randomized clinical trials
- (2019) Brian D. Moseley et al. EPILEPSY RESEARCH
- Is brivaracetam-induced elevation of carbamazepine-epoxide levels common and clinically relevant? — A case series
- (2019) Bernhard J. Steinhoff et al. EPILEPSY RESEARCH
- The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection
- (2019) Alberto Verrotti et al. Expert Review of Neurotherapeutics
- Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus
- (2018) Adam Strzelczyk et al. EPILEPSIA
- Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model
- (2018) Nathalie T. Sanon et al. EPILEPSY & BEHAVIOR
- Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program
- (2018) Martin J. Brodie et al. EPILEPSY RESEARCH
- Pharmacokinetics and Drug Interaction of Antiepileptic Drugs in Children and Adolescents
- (2018) Giulia Iapadre et al. PEDIATRIC DRUGS
- Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany
- (2018) Laurent M. Willems et al. Frontiers in Neurology
- BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice
- (2018) Vicente Villanueva et al. ACTA NEUROLOGICA SCANDINAVICA
- Postmarketing experience with brivaracetam in the treatment of focal epilepsy in children and adolescents
- (2018) Susanne Schubert-Bast et al. EPILEPSY & BEHAVIOR
- Cannabinoids for epilepsy: What do we know and where do we go?
- (2017) Martin J. Brodie et al. EPILEPSIA
- Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany
- (2017) Isabel Steinig et al. EPILEPSIA
- Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years
- (2017) Rik Schoemaker et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy
- (2017) Emilio Russo et al. Expert Opinion on Drug Discovery
- Evaluation of brivaracetam: a new drug to treat epilepsy
- (2017) Jasmina R. Milovanović et al. EXPERT OPINION ON PHARMACOTHERAPY
- Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures
- (2017) John A. Kappes et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Brivaracetam and levetiracetam dose adjustments leading to behavioural adverse effects
- (2017) May Yung Tiet et al. POSTGRADUATE MEDICAL JOURNAL
- New developments in the management of partial-onset epilepsy: role of brivaracetam
- (2017) Giangennaro Coppola et al. Drug Design Development and Therapy
- Stereochemistry of the Brivaracetam Diastereoisomers
- (2016) Shi Qiu et al. CHIRALITY
- Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures
- (2016) Manuel Toledo et al. EPILEPSIA
- Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment
- (2016) Henrik Klitgaard et al. EPILEPSIA
- Brivaracetam for the treatment of epilepsy
- (2016) Pavel Klein et al. EXPERT OPINION ON PHARMACOTHERAPY
- Brivaracetam Population Pharmacokinetics and Exposure-Response Modeling in Adult Subjects With Partial-Onset Seizures
- (2016) Rik Schoemaker et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures
- (2015) Pavel Klein et al. EPILEPSIA
- An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam
- (2015) Stephen L. Yates et al. EPILEPSY & BEHAVIOR
- Brivaracetam and carbamazepine interaction in healthy subjects and in vitro
- (2015) Armel Stockis et al. EPILEPSY RESEARCH
- The efficacy and safety of brivaracetam at different doses for partial-onset epilepsy: a meta-analysis of placebo-controlled studies
- (2015) Xin Tian et al. EXPERT OPINION ON PHARMACOTHERAPY
- Modulation of the conformational state of the SV2A protein by an allosteric mechanism as evidenced by ligand binding assays
- (2013) V Daniels et al. BRITISH JOURNAL OF PHARMACOLOGY
- Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial
- (2013) Victor Biton et al. EPILEPSIA
- Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial
- (2013) Patrick Kwan et al. EPILEPSIA
- Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: A phase IIb, randomized, controlled trial
- (2012) Wim Van Paesschen et al. EPILEPSIA
- Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties
- (2011) Michel Gillard et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Down-regulation Synaptic Vesicle Protein 2A in the Anterior Temporal Neocortex of Patients with Intractable Epilepsy
- (2009) Guibo Feng et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men
- (2008) Paul Rolan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A
- (2008) A Matagne et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More